Please assess the completion status of the following clinical trial:

Trial Title: TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* Athletes with an acute unilateral ankle sprain of the lateral ligaments of the ankle joint both male and female~* Moderate (30-60 mm) to severe (\>60 mm) pain according to the patient's assessment of ankle pain visual analogue scale (VAS) on weight bearing, unable to perform normal training / sports activities~* 18 - 40 years of age~* injury occurred within 24 hours of the first dose of study medication~* Willing and able to give written informed consent~* Available for the duration of the study~Exclusion Criteria:~* Similar injury affecting the same joint within the past 6 months~* bilateral ankle injury~* bed rest, hospitalization, surgery use of a non-removable rigid cast~* Clinically important abnormality for screening laboratory tests~* Debilitating acute or chronic illness~* Use of corticosteroids in the previous 8 weeks, any analgesics in the previous 6 hours, or 24 hours in case of long-acting NSAID, COX-2 specific inhibitors, or tramadol~* History of sensitivity to any component of the study drugs~* Unwilling or unable to comply with all the requirements of the protocol~* Participation in other studies within 4 weeks prior to study entry and or during the study participation~* Current substance or alcohol abuse that in the opinion of the investigator would interfere with compliance or with interpretation of the study result

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Traumeel S ointment (Type: EXPERIMENTAL): Traumeel S ointment 2 g, 3 times daily topical during 14 days
- Traumeel S gel (Type: EXPERIMENTAL): Traumeel S gel 2 g, 3 times daily topical during 14 days
- Diclofenac gel (Type: ACTIVE_COMPARATOR): Diclofenac gel 2 g, 3 times daily topical during 14 days

Based on this trial design, predict the completion outcome and termination type (if applicable).